EBS: Williams Paul Anthony discloses a sale
By AlphaYouPublished Form 4
Williams Paul Anthony
Reporting filer
Williams Paul Anthony reported Sale in Emergent BioSolutions Inc.: 3000 units of Common Stock, dated 2026-10-01. The full Form 4 contains 1 transaction entry.
- Disclosed
- Oct 5, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Williams Paul Anthony | 2026-10-01 | S | Sale | 3000 | 6.53 | 156,098 | 4 days | Filed terms
|
Common Stock
- Owner
- Williams Paul Anthony
- Date
- 2026-10-01
- Code
- S
- Action
- Sale
- Quantity
- 3000
- Price
- 6.53
- Following holdings
- 156,098
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-01
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- transaction Shares: 3000
- id: F1
- transaction Price Per Share: 6.53
- id: F2
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 156098
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Williams Paul Anthony: SVP, Products Business.
- The filing reports a Rule 10b5-1 trading plan.
- F1: All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on November 14, 2025 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.
- F2: The price reported in Column 4 is a weighted average price for sales executed on the same day within a one-dollar price range. These shares were sold in multiple transactions at prices ranging from $6.52 to $6.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Original sources
Prepared automatically from public filing data. Report a correction.